Short Induction Chemo Improves Survival in Advanced Cervical Cancer
Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.
Read MoreNov 2, 2023
Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.
Read MoreNov 2, 2023
Nivolumab plus chemotherapy is the first combination to outperform chemotherapy alone as first-line treatment for unresectable or metastatic urothelial cancer.
Read MoreNov 2, 2023
Patients with KRAS (G12C)-mutated, metastatic colorectal cancer (CRC) benefit from combination sotorasib and panitumumab
Read MoreNov 2, 2023
Soluble LAG-3 protein eftilagimod alpha combined with pembrolizumab shows promising clinical efficacy as first-line treatment for advanced or metastatic NSCLC.
Read MoreNov 2, 2023
If every patient is unique, can an overarching metric really be pinned down enough to declare that a given doctor was negligent as a legal certainty?
Read MoreNov 1, 2023
An innovative, curated ebook featuring insightful IBS-C findings and input from key opinion leaders in the field of gastroenterology.
Read MoreNov 1, 2023
Collaboration among healthcare providers and community-based organizations may be a viable strategy to increase PrEP uptake among Latino MSM.
Read MoreOct 31, 2023
Selecting a treatment for operable non-small cell lung cancer from the many options available involves consideration of tumor stage and biomarkers.
Read MoreOct 31, 2023
Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts.
Read MoreOct 31, 2023
Women are underrepresented in leadership positions in a wide range of industries, and medicine is no exception. Healthcare organizations can do more for women.
Read MoreOct 30, 2023
Medical education faces challenges that affect the quality of training and the preparedness of future healthcare workforce.
Read MoreOct 30, 2023
Patients with HIV and NAFLD experience a greater risk for adverse cardiovascular outcomes than those with HIV alone.
Read MoreOct 27, 2023
Resting-state functional MRI results show that patients with schizophrenia and tardive dyskinesia have altered cerebral regional homogeneity.
Read MoreOct 27, 2023
Selpercatinib doubled progression-free survival, increased response rate, and delayed pulmonary and physical deterioration in RET fusion-positive NSCLC.
Read MoreOct 27, 2023
Active surveillance after neoadjuvant chemoradiotherapy may be an alternative to surgery for some with esophageal cancer.
Read MoreOct 27, 2023
Toripalimab added to etoposide plus cisplatin or carboplatin improved survival in extensive-stage small cell lung cancer.
Read MoreOct 27, 2023
Pembrolizumab plus neoadjuvant chemotherapy in early-stage, high-risk ER+/HER2- breast cancer leads to a statistically significant increase in pathological complete response.
Read MoreOct 27, 2023
Nivolumab/relatlimab neoadjuvant treatment of deficient mismatch repair colon cancer shows impressive pathological response rates.
Read MoreOct 27, 2023
First-line enfortumab vedotin (EV) plus pembrolizumab significantly improved survival in patients with locally advanced or metastatic urothelial cancer.
Read More